$31.82
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Kymera Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:KYMR | Benzinga
Kymera Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.750
Quarterly Revenue Estimate
$16.18M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$47.07M
Analyze the earnings history of Kymera Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics | -$0.69 | -$0.75 | — | — | $10.29M | $16.18M | — | — | 05/01/2025 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.25 | -$0.79 | -$0.88 | -11.39% | $47.88M | $14.81M | $7.39M | -50.07% | 02/27/2025 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.90 | -$0.84 | -$0.82 | 2.38% | $4.73M | $10.36M | $3.74M | -63.89% | 10/31/2024 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.67 | -$0.68 | -$0.58 | 14.71% | $16.51M | $12.55M | $25.65M | 104.38% | 08/07/2024 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.70 | -$0.73 | -$0.69 | 5.48% | $9.47M | $13.69M | $10.29M | -24.86% | 05/02/2024 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.60 | -$0.40 | -$0.25 | 37.50% | $16.14M | $41.96M | $47.88M | 14.12% | 02/22/2024 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.79 | -$0.72 | -$0.90 | -25.00% | $9.55M | $15.97M | $4.73M | -70.39% | 11/02/2023 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.78 | -$0.71 | -$0.67 | 5.63% | $11.51M | $14.06M | $16.51M | 17.45% | 08/03/2023 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.71 | -$0.68 | -$0.70 | -2.94% | $9.62M | $14.15M | $9.47M | -33.10% | 05/04/2023 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.66 | -$0.63 | -$0.60 | 4.76% | $15.28M | $21.58M | $16.14M | -25.21% | 02/23/2023 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.56 | -$0.74 | -$0.79 | -6.76% | $20.34M | $15.51M | $9.55M | -38.42% | 11/03/2022 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.55 | -$0.72 | -$0.78 | -8.33% | $18.52M | $13.84M | $11.51M | -16.81% | 08/09/2022 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.29 | -$0.66 | -$0.71 | -7.58% | $18.70M | $16.23M | $9.62M | -40.71% | 05/03/2022 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.29 | -$0.57 | -$0.66 | -15.79% | $12.79M | $21.31M | $15.28M | -28.32% | 02/24/2022 | Get Alert |
| KYMR | Kymera Therapeutics | -$0.39 | — | -$0.56 | — | $14.53M | — | $20.34M | — | 11/10/2021 | Get Alert |
| KYMR | Kymera Therapeutics | — | -$0.26 | -$0.55 | -111.54% | $3.30M | $18.81M | $18.52M | -1.55% | 08/06/2021 | Get Alert |
| KYMR | Kymera Therapeutics | -$10.23 | -$0.19 | -$0.29 | -52.63% | — | $19.80M | $18.70M | -5.55% | 05/06/2021 | Get Alert |
| KYMR | Kymera Therapeutics | -$6.06 | — | -$0.29 | — | $1.83M | — | $12.79M | — | 03/11/2021 | Get Alert |
| KYMR | Kymera Therapeutics | — | — | -$0.39 | — | $950.00K | — | $14.53M | — | 11/05/2020 | Get Alert |
Kymera Therapeutics (KYMR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.88 | $-0.79 | -11.4 % |
| Q3 | 2024-10-31 | $-0.82 | $-0.84 | 2.38 % |
| Q2 | 2024-08-07 | $-0.58 | $-0.68 | 14.7 % |
| Q1 | 2024-05-02 | $-0.69 | $-0.73 | 5.48 % |
Kymera Therapeutics (KYMR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $7.39M | $14.81M | -50.1 % |
| Q3 | 2024-10-31 | $3.74M | $10.36M | -63.9 % |
| Q2 | 2024-08-07 | $25.65M | $12.55M | 104.4 % |
| Q1 | 2024-05-02 | $10.29M | $13.69M | -24.9 % |
FAQ
When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?
Kymera Therapeutics (KYMR) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Kymera Therapeutics (NASDAQ:KYMR)?
The Actual EPS was $-0.88, which missed the estimate of $-0.79.
What were Kymera Therapeutics’s (NASDAQ:KYMR) revenues?
The Actual Revenue was $7.4M, which missed the estimate of $14.8M.
Browse earnings estimates, EPS, and revenue on all stocks.